GRP and small cell lung carcinoma: For example, it has been recently shown that the CD133+ cells of small cell lung cancer expressed elevated levels of GRP, and a novel neuropeptide antagonist, peptide-1, is able to inhibit the growth of these cells.53 Therefore, it remains to be investigated the diverse roles of neuropeptides in various aspects of CSC’s biology.